Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

110 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Tyrosine kinase inhibitors as initial therapy for patients with chronic myeloid leukemia in accelerated phase.
Ohanian M, Kantarjian HM, Quintas-Cardama A, Jabbour E, Abruzzo L, Verstovsek S, Borthakur G, Ravandi F, Garcia-Manero G, Champlin R, Pierce S, Alattar ML, Trinh LX, Luthra R, Ferrajoli A, Kadia T, O'Brien S, Cortes JE. Ohanian M, et al. Clin Lymphoma Myeloma Leuk. 2014 Apr;14(2):155-162.e1. doi: 10.1016/j.clml.2013.08.008. Epub 2013 Dec 9. Clin Lymphoma Myeloma Leuk. 2014. PMID: 24332214 Free PMC article.
Acute myeloid leukemia with MYC rearrangement and JAK2 V617F mutation.
Ohanian M, Bueso-Ramos C, Ok CY, Lin P, Patel K, Alattar ML, Khoury JD, Rozovski U, Estrov Z, Huh YO, Cortes J, Abruzzo LV. Ohanian M, et al. Cancer Genet. 2015 Nov;208(11):571-4. doi: 10.1016/j.cancergen.2015.06.004. Epub 2015 Jun 25. Cancer Genet. 2015. PMID: 26382622 Free PMC article.
Dorsal column myelopathy after intrathecal chemotherapy for leukemia.
Pinnix CC, Chi L, Jabbour EJ, Milgrom SA, Smith GL, Daver N, Garg N, Cykowski MD, Fuller G, Cachia D, Kamiya-Matsuoka C, Woodman K, Dinardo C, Jain N, Kadia TM, Pemmaraju N, Ohanian M, Konopleva M, Kantarjian HM, Dabaja BS. Pinnix CC, et al. Among authors: ohanian m. Am J Hematol. 2017 Feb;92(2):155-160. doi: 10.1002/ajh.24611. Am J Hematol. 2017. PMID: 27874212 Free PMC article.
Frontline treatment of acute myeloid leukemia in adults.
Tamamyan G, Kadia T, Ravandi F, Borthakur G, Cortes J, Jabbour E, Daver N, Ohanian M, Kantarjian H, Konopleva M. Tamamyan G, et al. Among authors: ohanian m. Crit Rev Oncol Hematol. 2017 Feb;110:20-34. doi: 10.1016/j.critrevonc.2016.12.004. Epub 2016 Dec 11. Crit Rev Oncol Hematol. 2017. PMID: 28109402 Free PMC article. Review.
Characteristics and outcomes of older patients with secondary acute myeloid leukemia according to treatment approach.
Boddu PC, Kantarjian HM, Ravandi F, Garcia-Manero G, Verstovsek S, Jabbour EJ, Takahashi K, Bhalla K, Konopleva M, DiNardo CD, Ohanian M, Pemmaraju N, Jain N, Pierce S, Wierda WG, Cortes JE, Kadia TM. Boddu PC, et al. Among authors: ohanian m. Cancer. 2017 Aug 15;123(16):3050-3060. doi: 10.1002/cncr.30704. Epub 2017 Apr 7. Cancer. 2017. PMID: 28387922 Free PMC article.
Liposomal Grb2 antisense oligodeoxynucleotide (BP1001) in patients with refractory or relapsed haematological malignancies: a single-centre, open-label, dose-escalation, phase 1/1b trial.
Ohanian M, Tari Ashizawa A, Garcia-Manero G, Pemmaraju N, Kadia T, Jabbour E, Ravandi F, Borthakur G, Andreeff M, Konopleva M, Lim M, Pierce S, O'Brien S, Alvarado Y, Verstovsek S, Wierda W, Kantarjian H, Cortes J. Ohanian M, et al. Lancet Haematol. 2018 Apr;5(4):e136-e146. doi: 10.1016/S2352-3026(18)30021-8. Epub 2018 Mar 14. Lancet Haematol. 2018. PMID: 29550383 Clinical Trial.
110 results